arrow
S

Sophie Vaux

Sante Publique France
H指数:25
被引数:3,922

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023-January 2024
2024-06-0510
OA
Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France
2022-06-2867
OAAI
Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021-January 2022: A retrospective, population-based, matched cohort study

法国2021年12月2022年1月Sars-CoV-2 Omicron和Delta变体症状感染后的严重医院事件: 一项回顾性、以人群为基础的匹配队列研究

2022-06-0139
OAAI
Underdetection of cases of COVID-19 in France threatens epidemic control
Nature
IF48.5
2020-12-210
PREAI
Cluster of Coronavirus Disease 2019 (COVID-19) in the French Alps, February 2020

2020年2月法国阿尔卑斯山的冠状病毒疾病2019 (新型冠状病毒肺炎)

2020-04-11190
OAAI
Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study

在欧洲产生碳青霉烯酶的肠杆菌科 (EuSCAPE) 调查中产生碳青霉烯酶的肺炎克雷伯菌和大肠杆菌的发生: 一项前瞻性,跨国研究

2017-02-01519
OAAI